Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to the Presentation of Alligator Bioscience´s Interim Report January - March 2022 on April 27, 2022

LUND (Sweden) – April 22, 2022 – Alligator Bioscience will host a conference call (in English) for investors, analysts and media on Wednesday, April 27, 2022, at 15:30 CET. Alligator will publish the company's interim report on Wednesday, April 27, 2022, at 8:00 CET. CEO, Søren Bregenholt and CFO, Marie Svensson will present the interim report for the period January – March 2022 Report followed by a Q&A session. The conference call will be broadcast live on the web and can be accessed via the link: Alligator Bioscience , Audiocast with teleconference, Q1, 2022 | Financial Hearings (

InCoax wins additional order of 3 MSEK from US Fiber/LAN Operator

InCoax secures an additional order of 3 MSEK from the US based Fiber/LAN Operator with whom InCoax signed a Master Purchase Agreement in December 2021. The order will be supplied and invoiced during May 2022.The Operator currently has approximately half a million subscribers and is active in 19 US metropolitan areas of which InCoax is installed in nine of them. The InCoax MoCA Access 2.5 platform is a cost-effective and fast way compared to Fiber/LAN to execute the fiber deployment strategy in Multi-Dwellings Units (MDUs) all the way to the consumer. Implementing the InCoax Fiber Access

Invitation to the presentation of Bactiguard’s interim report for the first quarter and ahead of the AGM 2022

Bactiguard Holding AB (publ) publishes the interim report for the first quarter of 2022 on Wednesday, April 27, 2022, at 08.00 and holds the Annual General Meeting via postal vote on April 29, 2022.In connection with this, an audiocast for shareholders, investors and analysts will be held at 11:00 CET on April 27. CEO Anders Göransson and CFO Gabriella Björknert Caracciolo will present the interim report and answer questions. The report and a presentation for the audiocast will be available at Bactiguard’s website www.bactiguard.com. To participate in the webcast, please use this link:

The Board of Directors of Aiforia Technologies Plc decided on two new option rights plans

Aiforia Technologies Plc, Company release, 22 April 2022 at 9.30 a.m. EEST. The Board of Directors of Aiforia Technologies Plc ("Aiforia") has on 21 April 2022 decided to launch new option right plans 2022 I and 2022 II as described below. There is a weighty financial reason for Aiforia to issue option rights as the option rights are intended to form a part of the Aiforia's incentive and commitment programme for members of the management team of the company, key personnel of the company and its subsidiaries as well as other persons fundamental to the company and its subsidiaries.Option

Mandatory notification of trade

Anooj Unarket, Board member of Otello Corporation ASA, has on behalf of certain related parties, as of 21st April 2022, acquired interests in shares of Otello Corporation ASA. The balance of Anooj Unarket and related parties’ holdings after the transaction totals 27,735,037 shares. Please refer to the attached notification of trading for further details. This information is subject to disclosure requirements in regulation EU 596/2014 article 19 number 3 and the Norwegian Securities Trading Act section 5-12.

SGL International A/S publishes bond prospectus and applies for listing of its subsequent bonds on Nasdaq Stockholm

SGL International A/S (the "Company") has issued a senior secured floating rate subsequent bonds in an amount of EUR 75,000,000 on 23 February 2022 under its EUR 350,000,000 bond framework with ISIN SE0015810759 (the "Subsequent Bonds"). Following the issuance of the Subsequent Bonds the total outstanding amount of the Company's bond loan with ISIN SE0015810759 is EUR 300,000,000. The Company will apply for listing of the Subsequent Bonds on the Corporate Bond list of Nasdaq Stockholm. The Subsequent Bonds will be admitted to trading at Nasdaq Stockholm as soon as possible. In

Heliospectra (publ) Publish Interim Report for January-March 2022

(GOTHENBURG, Sweden, April 22, 2022, at 08:30 CET)– Heliospectra AB (publ), a leader in intelligent lighting technology for greenhouse and controlled plant growth environments, presents its Interim Report for January-March 2022.Full report is enclosed to this press release and is also uploaded at https://www.heliospectra.com/investor-relations/reports-documents-archive. SUMMARY OF REPORT SALES AND FINANCIAL PERFORMANCE, JANUARY– MARCHOrder intake during the period January to March amounted to SEK 2,041 (12,535) thousand. Net sales during the period January to March amounted to

Interim report Q1 January – March 2022

More than doubling sales and earningsFirst quarter in summary January–March 2022 · Net sales SEK 488,1m (201,7), +142 percent (13 percent organic) · EBITA result SEK 73,4m (28,7), +156 percent · EBIT result SEK 67,7m (24,9) +172 percent · Items affecting comparability SEK 0,6m[ ](2,7) · Profit before tax SEK 64,1m (25,7) · Earnings per share SEK 1,49 (0,96) · Cash flow from operating activities SEK 57,7m (1,5) Important events during the quarter · Svedbergs carries out a successful rights issue that yields SEK 480m after issue costs. The issue was

BioStock: Emplicure building strong patent portfolio

In life science, robust and sustainable intellectual property protection is crucial for optimising the value of a company’s development project. This fact has motivated Uppsala-based Emplicure to work actively to strengthen the patent protection for its products. Since December, the company has announced four patent advancements in strategically important markets. BioStock contacted Emplicure’s co-founder Thomas Lundqvist, who has extensive experience in patent protection, to find out more.Read the full interview at biostock.se: https://www.biostock.se/en/2022/04/emplicure-building-

Nordea cancels repurchased shares

Nordea Bank AbpStock exchange release – Total number of voting rights and capital22 April 2022 at 9.15 EET Nordea Bank Abp (“Nordea”) has today cancelled 21,558,763 treasury shares, which were held for capital optimisation purposes and acquired through share buy-backs, in line with the decision by the Board of Directors. The cancellation of the treasury shares has been registered with the Finnish Trade Register on 22 April 2022. After the cancellation, the total number of shares in Nordea is 3,838,758,570 and the total number of votes attached to the shares is 3,838,758,570.

HusCompagniet acquires prefab factory to accelerate production in the growing semi-detached segment – mid-term sales target increased from 500 to 750 units a year towards 2025

HusCompagniet A/S (“HusCompagniet”) has signed agreement to acquire prefabricated (prefab) factory from NVV GmbH and JAWS Holding ApS (“Danhaus”) including order book of around DKK 200 million. The factory is in Esbjerg, Denmark. Closing is expected to be in May 2022.Company announcement 20/2022 The factory is one of the most well-automated factories in the Nordics and entering this part of the supply chain in Denmark will further strengthen HusCompagniets strategic ambitions. Prefab is especially well suited for more sustainable semi-detached new-builds such as DGNB-certified projects

Interim report 1 January – 31 March 2022

Good organic growth despite supply chain disruptionsFIRST QUARTER 2022 · Net sales increased by 21 percent to MSEK 205 (170). In unchanged currency levels, net sales increased by 18 percent. · Operating profit after depreciation/amortization decreased by 5 percent to MSEK 15 (16), including negative currency effects of MSEK -0.1 (-0.5). During 2021, operating profit was burdened by direct acquisition costs of MSEK -1.4. · Cash flow from operating activities amounted to MSEK 5.9 (20). · Earnings per share amounted to SEK 0.55 (0.61). · Solidity amounted to 67 (49) percent.

Exel Composites Plc publishes its Q1 2022 Business Review on 29 April 2022

EXEL COMPOSITES PLC      INVESTOR NEWS      22 APRIL 2022 at 09:00 EETExel Composites Plc publishes its Q1 2022 Business Review on Friday 29 April 2022 at approximately 9:00 EET. A financial results briefing for investors, analysts and journalists will be held the same day at 12:30 EET. The briefing will be hosted by Riku Kytömäki, President and CEO.   The briefing will be organized online. Participants are requested to register to the event in advance by sending an email to investor@exelcomposites.com no later than by Wednesday 27 April 2022 at 16:00 EET. A link to join the event

Caverion donates to the John Nurminen Foundation – towards efforts to save the Baltic Sea for future generations

Caverion Corporation Press release 22 April 2022 at 9.00 a.m. EESTCaverion donates to the John Nurminen Foundation – towards efforts to save the Baltic Sea for future generations On International Earth Day 2022, Caverion donates EUR 20,000 to the John Nurminen Foundation. "The many concerns we face in Europe at the moment highlight the need to work together across a broad front to achieve the green transition. Our donation to the John Nurminen Foundation is the culmination of many sustainability-related activities and events carried out over the past months by our employees as well as

CapMan to publish its 1–3 2022 Interim Report on Thursday 28 April 2022

CapMan Plc press release                              22 April 2022 at 9.00 a.m. EEST CapMan to publish its 1–3 2022 Interim Report on Thursday 28 April 2022 CapMan will publish its Interim Report for the period 1 January–31 March 2022 on Thursday 28 April 2022 around 8.00 a.m. EEST. The company will present the results for the review period over a webcast press conference starting at 9.30 a.m. EEST accessible at https://capman.videosync.fi/2022-q1-results. The conference will be held in English. The report and presentation material will be available at CapMan’s website after the

Vitec Software Group AB Interim report January - March 2022

Summary of interim period, January–March 2022 · Net sales SEK 447 million (373), an increase of 20% · Recurring revenues SEK 378 million (313), an increase of 21% including 8% organic · EBITA was SEK 130 million (96), an increase of 36% · EBITA margin 29% (26) · Operating profit was SEK 83 million (56), an increase of 50% · Operating margin 19% (15) · Earnings per share before dilution SEK 1.76 (1.21) · Cash flow from operating activities SEK 445 million (310) · Acquisition DocuBizz ApS Increased marketing activities, development initiatives and continued

Adjusted comparative figures due to changes in business segments and accounting of mandatory government fees

During Q1 2022, the Bank carried out a reorganisation in order to create a more focused organisation, closer to the customer. The main accounting effect arises from the Savings & Pension unit moving from Capital Markets to the Sweden business segment, with the exceptions of the local units in Savings & Pension that move to the Norway, Finland and Denmark business segments, respectively. In addition, some central functions that today work closely with the Sweden business segment are moving from Other units to the Sweden business segment. As of Q1 2022, the resolution fee will no longer be

Terrafame’s operating result increased to EUR 13.5 million

(The financial information presented about Terrafame Ltd in this bulletin consists of unaudited FAS figures. The figures in brackets refer to the corresponding period of the previous year unless otherwise stated.) January–March 2022 in brief: · Net sales from battery chemicals business were EUR 46.5 (0) million which represents around 37% of the total net sales. The ramp-up of production is progressing. · Net sales from metal intermediate business were EUR 80.6 (93.4) million. · Total net sales were EUR 127.0 (93.4) million, representing an increase of 36.0% year-on-year. The

Saga Pure ASA: Annual Report 2021

(Oslo, 22 April 2022) Saga Pure ASA (Saga Pure, OSE:SAGA) has published its Annual Report for 2021. The report is attached to this stock exchange notice and published on www.sagapure.com. For further information, please contact: Bjørn Simonsen, CEO, +47 971 79 821 Espen Lundaas, CFO +47 92 43 14 17 About Saga Pure | www.sagapure.com Saga Pure ASA is an investment company focusing on opportunities within renewable energy, hydrogen, circular economy and CO2-reduction. This stock exchange notice is subject to the disclosure requirements in Section 5-12 of the Norwegian

EVLI PLC AND EAB GROUP PLC CONSIDER COMBINATION

EAB Group Plc, Inside Information, Stock Exchange Release, 22 April 2022, 9:00 a.m. (EET)   NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. FOR FURTHER INFORMATION SEE SECTION ”IMPORTANT NOTICE” BELOW. EVLI PLC AND EAB GROUP PLC CONSIDER COMBINATION   Today on April 22, 2022, Evli Plc (“Evli”) and EAB Group Plc (“EAB”) have signed a letter of intent (“Letter of Intent”), pursuant to which the parties are looking into a potential combination of Evli’s and EAB’s operations (“

Last day for trading in BoMill’s shares including the right to participate in share issue

The last day of trading in the BoMill share including the right to obtain subscription rights is today, April 22[nd], 2022 and the first day of trading in the BoMill share excluding the right to obtain subscription rights is April 25[th], 2022.At the Extraordinary General Meeting on April 8[th], 2022, it was decided to issue new shares with preferential rights for shareholders in BoMill of approximately SEK 23.3 million. The Rights Issue is secured through underwriting commitments corresponding to 100 percent of the maximum issue volume. Briefly about the Rights Issue · Anyone who

Interim report January–March 2022: Building on our strong growth momentum

First quarter · Sales of SEK 752 (379) million, corresponding to an increase of 98% in SEK whereof currency effect 13%, acquired growth 74% and organic growth 11%. · Consumables increased sales by 26% in SEK, Technologies by 4% in SEK, and Genetic Services contributed with sales of SEK 304 million. · Strong growth in all market regions: Americas 255%, EMEA 85%, Japan Pacific 21% and Asia 19% in local currencies. · Operating income before depreciation and amortisation (EBITDA) was SEK 228 (163) million, corresponding to a margin of 30.4% (43.0). EBITDA per share increased 13%.

Annexin announces allowance of a new U.S. Patent covering manufacturing of ANXV

Annexin Pharmaceuticals AB (publ) announces that the U.S. Patent and Trademark Office has allowed an issue of the new patent, further strengthening the intellectual property and key coverage for the Annexin ‘s therapeutic product candidate ANXV.STOCKHOLM (22 April, 2022) - ANXV is a human Annexin A5 produced by recombinant technology in a living bacterial system. Production processes of biologic drug candidates such as ANXV are highly complex.  A considerable amount of time, knowledge, efforts and investments are required to produce such proteins at a quality and quantity that are

There are no items matching the current filter
There are no more items matching the current filter
Back to top